-- Mary Elizabeth Dallas
THURSDAY, July 31, 2014 (HealthDay News) -- Recovery time after
surgery may be reduced for patients taking the cholesterol-lowering
medications known as statins, according to a new study.
The study's Irish researchers suspect that the drugs may affect
the body's inflammatory response, reducing the amount of time
surgical patients' wounds need to heal. And that seemed to be
particularly true among people who tend to have healing
"Statins have become one of the most widely prescribed medications in the world. While they are typically used to manage high cholesterol levels, a number of researchers have been investigating the benefits of statins in other conditions, such as severe infections or following organ transplantation," said the study's lead author, Dr. Gerard Fitzmaurice, from Our Lady's Children's Hospital in Dublin, Ireland, in a news release from the Society for Thoracic Surgeons.
In conducting the study, the researchers analyzed existing data
on statins, most of which was from lab-based studies involving
animals. They found that statins reduced the amount of time needed
to recover after surgery from about 19 days to 13 days, according
to the study.
Statins could improve wound healing in patients who've underdone
any type of procedure, including heart surgery, the researchers
concluded. This could result in smaller scars, they pointed
"Normal wound healing involves a series of phases that ultimately leads to a scar. Many things can affect this process and it's difficult to determine exactly how statins might improve wound healing, but it would appear that they influence a number of factors in the inflammatory response," noted Fitzmaurice. "Our analysis also shows that some statins are better at it than others."
Although the overall rate of chest wound infections is low --
only about 1 percent -- faster healing times might reduce this rate
even further, especially for people with slow-healing wounds due to
underlying health issues, such as diabetes.
"Based on the encouraging results in the systematic review, we would recommend consideration of an appropriately conducted, randomized-controlled, double-blind clinical trial to comprehensively assess the potential role of topical statins in the promotion of postoperative wound healing," concluded Fitzmaurice.
The U.S. National Institutes of Health provides more information
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.